| Previous Close | 35.9700 |
| Open | 36.1000 |
| Bid | 35.9400 x 2900 |
| Ask | 35.9500 x 1500 |
| Day's Range | 35.8800 - 36.1200 |
| 52 Week Range | 29.8300 - 36.2100 |
| Volume | 1,772,327 |
| Avg. Volume | 17,208,645 |
| Market Cap | 213.78B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.29 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.61%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Zacks•38 minutes ago
Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval
Pfizer and German partner Merck KGaA's Bavencio secures an EU approval for metastatic Merkel cell carcinoma. The company also expects to make the drug commercially available within a month.
- Market Realist•1 hour ago
What Pfizer’s Valuation Changes after 2Q17 Tell Us
Analysts estimate that Pfizer (PFE) stock has the potential to return ~5.9% over the next 12 months.
- Zacks•2 hours ago
Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com
The Dow mopped up gains over the week, buoyed by announcements from the Federal Reserve.
